Theodore M Brasky, PhD
College of Medicine
Breast Cancer, Cancer, Prostatic Cancer, Inflammation, Endometrial Cancer, Lung Cancer, Hematologic Cancer, Pancreatic Cancer, Melanoma, Small Cell Lung Carcinoma
Theodore Brasky, PhD, is a member of the nationally recognized Cancer Control team at the OSUCCC – James. His research is centered on further understanding the link between inflammation and cancer.
Specifically, Dr. Brasky studies how anti-inflammatory medications and nutrients with anti-inflammatory properties affect cancer occurrence, progression and survival. For example, his recent research has included the exploration of whether dietary intake of long-chain omega-3 fatty acids are associated with endometrial cancer risk, and separately, whether the use of non-steroidal anti-inflammatory drugs are associated with survival or recurrence from the disease. Although recent projects include endometrial cancer, his interests are broad and include the study of many solid tumors including cancers of the breast, prostate, and lung, among others. Dr. Brasky additionally holds research interests in tobacco control, focusing on the health effects of electronic cigarette use among cancer patients.
Dr. Brasky has authored or co-authored more than 60 peer-reviewed journal articles for publication. His work is featured in impactful journals for his field including the Journal of Clinical Oncology, Journal of the National Cancer Institute, International Journal of Cancer, American Journal of Clinical Nutrition, and the American Journal of Epidemiology. He also sits on the editorial board of the journal Gynecologic Oncology.
Education and Background
BA, University at Buffalo
Buffalo, NY (USA)
Master's Degree, University of Massachusetts-Amherst
Amherst, MA (USA)
Post Doctorate Train, University at Buffalo
Buffalo, NY (USA)